News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
185,044 Results
Type
Article (6441)
Company Profile (13)
Press Release (178589)
Multimedia
Podcasts (6)
Webinars (3)
Section
Business (50576)
Career Advice (74)
Deals (8055)
Drug Delivery (14)
Drug Development (27152)
Employer Resources (7)
FDA (4960)
Job Trends (3928)
News (85048)
Policy (8739)
Tag
Academia (632)
Accelerated approval (27)
ADA (20)
Allergies (70)
Alliances (11630)
ALS (101)
Alzheimer's disease (523)
Antibody-drug conjugate (ADC) (232)
Approvals (5497)
Artificial intelligence (331)
ASCO (162)
Autoimmune disease (143)
Automation (30)
Bankruptcy (59)
Best Places to Work (3622)
BIO (24)
Biosimilars (114)
Biotechnology (12)
Bladder cancer (156)
Brain cancer (34)
Breast cancer (436)
Cancer (3272)
Cardiovascular disease (251)
Career advice (70)
Career pathing (2)
CAR-T (113)
CDC (6)
Cell therapy (356)
Cervical cancer (27)
Clinical research (25645)
Collaboration (1051)
Compensation (612)
Complete response letters (27)
COVID-19 (1955)
CRISPR (63)
C-suite (520)
Cystic fibrosis (50)
Data (4690)
Decentralized trials (1)
Depression (81)
Dermatology (49)
Diabetes (246)
Diagnostics (2334)
Digital health (26)
Diversity (3)
Diversity, equity & inclusion (2)
Drug discovery (153)
Drug pricing (25)
Drug shortages (4)
Duchenne muscular dystrophy (117)
Earnings (23630)
Editorial (3)
Employer resources (6)
Events (30241)
Executive appointments (542)
FDA (7053)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (786)
Gene editing (107)
Generative AI (17)
Gene therapy (284)
GLP-1 (262)
Government (1342)
Grass and pollen (3)
Guidances (212)
Healthcare (4615)
Hematology (91)
HIV (59)
Huntington's disease (24)
IgA nephropathy (42)
Immunology and inflammation (56)
Immuno-oncology (35)
Indications (115)
Infectious disease (2153)
Inflammatory bowel disease (73)
Inflation Reduction Act (3)
Influenza (96)
Intellectual property (106)
Interviews (7)
IPO (3673)
IRA (7)
Job creations (603)
Job search strategy (66)
JPM (4)
Kidney cancer (14)
Labor market (7)
Layoffs (67)
Legal (1795)
Liver cancer (41)
Longevity (10)
Lung cancer (478)
Lymphoma (281)
Machine learning (29)
Management (2)
Manufacturing (389)
Marketing (5)
MASH (91)
Medical device (3121)
Medtech (3178)
Mergers & acquisitions (5018)
Metabolic disorders (502)
mRNA (75)
Multiple sclerosis (73)
NASH (5)
Neurodegenerative disease (167)
Neuropsychiatric disorders (32)
Neuroscience (1163)
NextGen: Class of 2026 (769)
Non-profit (847)
Now hiring (4)
Obesity (154)
Opinion (31)
Ovarian cancer (129)
Pain (106)
Pancreatic cancer (156)
Parkinson's disease (131)
Partnered (6)
Patents (195)
Patient recruitment (350)
Peanut (19)
People (12719)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase 1 (7180)
Phase 2 (10880)
Phase 3 (9765)
Pipeline (4848)
Policy (23)
Postmarket research (992)
Preclinical (2678)
Press Release (55)
Prostate cancer (180)
Psychedelics (6)
Radiopharmaceuticals (110)
Rare diseases (445)
Real estate (1196)
Recruiting (3)
Regulatory (8074)
Reports (10)
Research institute (759)
Resumes & cover letters (7)
Rett syndrome (37)
RNA editing (11)
RSV (47)
Schizophrenia (68)
Series A (124)
Series B (103)
Service/supplier (2)
Sickle cell disease (50)
Special edition (1)
Spinal muscular atrophy (73)
Sponsored (9)
Startups (527)
State (1)
Stomach cancer (1)
Supply chain (50)
Tariffs (6)
The Weekly (6)
Vaccines (505)
Venture capital (18)
Weight loss (57)
Women's health (51)
Worklife (1)
Date
Today (33)
Last 7 days (169)
Last 30 days (844)
Last 365 days (13307)
2026 (7330)
2025 (13900)
2024 (11228)
2023 (10672)
2022 (14729)
2021 (16009)
2020 (15814)
2019 (10067)
2018 (7427)
2017 (7468)
2016 (7016)
2015 (8446)
2014 (6096)
2013 (5043)
2012 (5699)
2011 (5844)
2010 (5822)
Location
Africa (112)
Alabama (25)
Arizona (58)
Arkansas (5)
Asia (9073)
Australia (1075)
California (5839)
Canada (1521)
China (496)
Colorado (276)
Connecticut (332)
Delaware (279)
Europe (23156)
Florida (595)
Georgia (184)
Hawaii (3)
Idaho (10)
Illinois (533)
India (50)
Indiana (155)
Iowa (10)
Japan (378)
Kansas (17)
Kentucky (10)
Louisiana (27)
Maine (6)
Maryland (478)
Massachusetts (4448)
Michigan (92)
Minnesota (216)
Mississippi (1)
Missouri (57)
Montana (2)
Nebraska (3)
Nevada (75)
New Hampshire (90)
New Jersey (3650)
New Mexico (25)
New York (1861)
North Carolina (1772)
North Dakota (11)
Northern California (2996)
Ohio (148)
Oklahoma (6)
Oregon (12)
Pennsylvania (847)
Puerto Rico (7)
Rhode Island (16)
South America (241)
South Carolina (6)
South Dakota (1)
Southern California (2191)
Tennessee (92)
Texas (910)
United States (23048)
Utah (86)
Virginia (139)
Washington D.C. (19)
Washington State (411)
West Virginia (2)
Wisconsin (113)
185,044 Results for "janssen pharmaceutica n v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vivoryon Therapeutics N.V. to Report Q1 2026 Financial Results on June 11, 2026
June 8, 2026
·
2 min read
Press Releases
Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results and Provides Business Update
June 11, 2026
·
9 min read
Press Releases
Vivoryon Therapeutics N.V. to Attend Upcoming Investor Conference
April 9, 2026
·
2 min read
Press Releases
Vivoryon Therapeutics N.V. Reports Full Year 2025 Financial Results and Provides Business Update
April 23, 2026
·
19 min read
Press Releases
Vivoryon Therapeutics N.V. to Report Full Year 2025 Financial Results and Business Updates on April 23, 2026
April 15, 2026
·
3 min read
Business
Alkermes Announces Second Interim Award in Janssen Pharmaceutica Arbitration
Alkermes plc (Nasdaq: ALKS) today announced that on April 19, 2023 it received a second interim award (the “Second Interim Award”) from the arbitral tribunal (the “Tribunal”) in its arbitration proceedings in respect of two license agreements with Janssen Pharmaceutica N.V.
April 25, 2023
·
4 min read
MustGrow and Janssen PMP, a division of Janssen Pharmaceutica NV, Announce Significant Project Expansion
MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”), and Janssen PMP, a division of Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) (“Janssen PMP”) are pleased to announce a significant expansion to their existing Exclusive Evaluation and Option Agreement
September 6, 2023
·
9 min read
Press Releases
Vivoryon Therapeutics N.V. to Attend and Present in Upcoming Conferences
January 7, 2026
·
3 min read
Press Releases
QIAGEN N.V. to Release Results for Q4 2025 and Hold Webcast
January 20, 2026
·
1 min read
MustGrow and Janssen PMP, a Division of Janssen Pharmaceutica NV, Extend Exclusive Global Partnership
MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”), and JANSSEN PMP, a division of Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson
May 23, 2023
·
7 min read
1 of 18,505
Next
